>Is there a comprehensive list of biological patent expirations?<
Since biopharmaceuticals are not listed in the FDA’s Orange Book, it’s not a simple matter to track exactly which patents apply to a given drug. Thus, compiling a comprehensive list of patent expirations for biopharmaceuticals is partly a subjective exercise that requires making a determination as to which patents are likely to stand up in the event that a regulatory pathway is opened for FDA approval of biogenerics. The same issue applies in other jurisdictions such as the EU.
If anyone does have a trustworthy list of biopharmaceutical patent expirations, please speak up!
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”